Current status of paclitaxel in the treatment of breast cancer (Q40524847)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1995

Language	Label	Description	Also known as
English	Current status of paclitaxel in the treatment of breast cancer	scientific article published on January 1995

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

Current status of paclitaxel in the treatment of breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

based on heuristic

inferred from title

Joyce O'Shaughnessy

1

object named as

J A O'Shaughnessy

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

K H Cowan

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 January 1995

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

27-37

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitivity reactions from taxol

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phosphoglycoprotein associated with taxol resistance in J774.2 cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol: a novel radiation sensitizer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol: mechanisms of action and resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel administration using portable infusion pumps

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promotion of microtubule assembly in vitro by taxol

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7749130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00666068

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40524847&oldid=2203758669"